Advanced search
Publication Cover
Acta Cardiologica Volume 65, 2010 - Issue 4
Submit an article Journal homepage
3
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Less iodine injected for the same diagnostic performances: comparison of two low-osmolar contrast agents (iobitridol 350 and iopamidol 370) in coronary angiography and ventriculography: a randomized double-blind clinical study

María Teresa VelÁzquezHospital Universitario Doce de Octubre, Madrid.Correspondence[email protected]
, MD,
Agust#x00ED;n AlbarranHospital Universitario Doce de Octubre, Madrid.
, MD,
Felipe HernÁndezHospital Universitario Doce de Octubre, Madrid.
, MD,
Julio GarcÍa TejadaHospital Universitario Doce de Octubre, Madrid.
, MD,
Javier ZuecoHospital Marqués de Valdecilla, Santander, Spain
, MD,
Javier AndreuHospital Universitario Doce de Octubre, Madrid.
, MD,
Jose-María De La TorreHospital Marqués de Valdecilla, Santander, Spain
, MD,
Alvaro FigueroaHospital Marqués de Valdecilla, Santander, Spain
, MD,
Ferm#x00ED;n SainzHospital Marqués de Valdecilla, Santander, Spain
, MD &
Juan TasconHospital Universitario Doce de Octubre, Madrid.
, MD show all
Pages 387-394 | Received 29 Mar 2010, Accepted 02 Jun 2010, Published online: 23 May 2017

References

  • Onnasch DG, Schemm A, Kramer HH. Optimization of radiographic parameters for paediatric cardiac angiography. Br J Radiol 2004; 77: 479–87.
  • Mezilis N, Salame MY, Dyet JF, Arafa SO, Oakley GD, Cumberland DC. Comparison of Iotrolan 320 and Iohexol 350 in cardiac angiography: a randomised double-blind clinical study. Eur J Radiol 1998; 28: 171–5.
  • Petersein J, Peters CR, Wolf M, Hamm B. Results of the safety and efficacy of iobitridol in more than 61,000 patients. Eur Radiol 2003; 13: 2006–11.
  • Katzberg RW, Barrett BJ. Risk of iodinated contrast mate-rial-induced nephropathy with intravenous administration. Radiology 2007; 243: 622–8.
  • Thomsen HS, Morcos SK, Barrett BJ. Contrast-induced nephropathy: the wheel has turned 360 degrees. Acta Radiol 2008; 49: 646–57.
  • Nyman U, Almen T, Aspelin P, Hellstrom M, Kristiansson M, Sterner G. Contrast-medium-induced nephropathy cor-related to the ratio between dose in gram iodine and esti-mated GFR in ml/min. Acta Radiol 2005; 46: 830–42.
  • Murdock DK, Euler DE, Becker DM, Murdock JD, Scan-lon PJ, Gunnar RM. Ventricular fibrillation during coro-nary angiography: an analysis of mechanisms. Am Heart J 1985; 109: 265–73.
  • Vijayalakshmi K, Williams D, Wright RA, Hall JA, Har-combe AA, Linker NJ, Stewart MJ, Davies A, de Belder MA. A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization. J Invasive Cardiol 2004; 16: 707–11.
  • Stacul F, Thomsen HS. Nonionic monomers and dimers. Eur Radiol 1996; 6: 756–61.
  • Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, Van-Fossen DB. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 1995; 47: 254–61.
  • Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of con-trast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44: 1393–9.
  • Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, Pichard AD, Satler LF, Leon MB. The prognos-tic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000; 36: 1542–8.
  • Briguori C, Manganelli F, Scarpato P, Elia PP, Golia B, Riviezzo G, Lepore S, Librera M, Villari B, Colombo A, Ricciardelli B. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2002; 40: 298–303.
  • Taliercio CP, Vlietstra RE, Ilstrup DM, Burnett JC, Menke KK, Stensrud SL, Holmes DR, Jr. A randomized compar-ison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography. J Am Coll Cardiol 1991; 17: 384–90.
  • Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephro-toxicity of high- and low-osmolality iodinated contrast media. Radiology 1993; 188: 171–8.
  • Jo SH, Youn TJ, Koo BK, Park JS, Kang HJ, Cho YS, Chung WY, Joo GW, Chae IH, Choi DJ, Oh BH, Lee MM, Park YB, Kim HS. Renal toxicity evaluation and compari-son between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol 2006; 48: 924–30.
  • Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients under-going angiography. N Engl J Med 2003; 348: 491–9.
  • Mehran R, Nikolsky E, Kirtane AJ, Caixeta A, Wong SC, Teirstein PS, Downey WE, Batchelor WB, Casterella PJ, Kim YH, Fahy M, Dangas GD. Ionic low-osmolar versus non-ionic iso-osmolar contrast media to obviate worsening nephmpathy after angioplasty in chmnic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate wors-ening Nephropathy after angioplasty in chronic renal failure patients) study. JACC Cardiovasc Interv 2009; 2: 415–21.
  • Lefevre T, Funck F, Aliot E, Ethevenot B. Safety and effi-cacy of the new iodinated nonionic low-osmolality contrast medium Iobitridol (Xenetix) in coronary and ventricular angiography. Acta Radiol Suppl 1996; 400: 75–80.
  • Vijayalakshmi K, Kunadian B, Wright RA, Hall JA, Stew-art MJ, Davies A, Sutton A, de Belder MA. A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iome-prol 350 (Iomeron) in cardiac catheterisation. Eur J Radiol 2007; 61: 342–50.
  • Nagamoto M, Gomi T, Terada H, Terada S, Kohda E. Eval-uation of the acute adverse reaction of contrast medium with high and moderate iodine concentration in patients undergoing computed tomography. Radiat Med 2006; 24: 669–74.
  • Masui T, Katayama M, Kobayashi S, Sakahara H. Intra-venous injection of high and medium concentrations of com-puted tomography contrast media and related heat sensa-tion, local pain, and adverse reactions. J Comput Assist Tomogr 2005; 29: 704–8.
  • Setty BN, Sahani DV, Ouellette-Piazzo K, Hahn PF, Shep-ard JA. Comparison of enhancement, image quality, cost, and adverse reactions using 2 different contrast medium con-centrations for routine chest CT on 16-slice MDCT. J Corn-put Assist Tomogr 2006; 30: 818–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.